Clinical Trial

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

Name: Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy — clinical trial record (NCT07405645)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MRg-FUS

Recruiting

View on ClinicalTrials.gov →

Summary

This phase 1 multi-site study investigates the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer and brachial cancer.

Trial Details

NCT Number	NCT07405645
Lead Sponsor	University of Virginia Collaborators: Focused Ultrasound Foundation
Conditions	Head Neck Cancer, Squamous Cell Cancer of Head and Neck (SCCHN), Cancer Pain
Enrollment	20 participants
Start Date	2026-02-15
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-12